Skip to main navigation Skip to search Skip to main content

Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute – Mexico, from 2000 to 2016

  • Jimena Ylescas‐Soria
  • , Alfredo H. de la Torre‐Lujan
  • , Luis A. Herrera
  • , Daniela Miranda
  • , Flavio Grimaldo
  • , Silvia Rivas
  • , Eduardo Cervera
  • , Abelardo Meneses‐García
  • , Fidias E. Leon-Sarmiento
  • , Diddier Prada

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
JournalCancer Medicine
DOIs
StatePublished - May 2 2019

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Internal Medicine

Cite this